Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-23-040615

Options or other derivatives

  • Chief Financial Officer acquired 432,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Musso Alan A · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-07 Grant or award : show line 1 in the form Stock Option (right to buy) +432,800 432,800 D
Loading xslF345X05/ownership.xml…